Interestingly, while ASXL1 variants drove significant upregulation of HOXA11 transcript expression (log2FC = 3.87, padj=1.33E-06) in AML-ASXL1, there was no significant dysregulation of HOXA11 in BOS. The gene discussed is ASXL1; the disease is acute myeloid leukemia.